SUNNYVALE, Calif., June 16, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the launch of RayStation* treatment planning support for the company's CyberKnife® M6™** and S7™** Robotic, Radiotherapy Systems. RayStation helps enable clinicians to create treatment plans for the CyberKnife M6 and S7 Systems and other conventional radiation therapy devices in one unified treatment planning system (TPS), making it easier to integrate the Accuray systems within the radiation oncology department. Integration will help to improve workflows and operational efficiency. RayStation can be combined with the Accuray data management system, iDMS®, to provide a single platform for treatment planning and data integration for CyberKnife treatments.
RayStation supports the creation of treatment plans that take full advantage of the capabilities of the CyberKnife, M6 and S7 robotic SRS/SBRT systems. Similar to the Accuray Precision® TPS, some of the key features enabled by the RayStation TPS include:
Indication-specific motion tracking and delivery adaptation with Accuray-only Synchrony® technology, which is used on the platform as a part of every treatment delivery
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
Delivery of non-coplanar, isocentric or non-isocentric treatment beams from potentially thousands of different angles
All collimator types - fixed, Iris™ Variable Aperture and the InCise™ Multileaf Collimators – for the widest range of treatments
Fast and accurate dose calculation that enables dose adjustment in real-time
Deformable registration and adaptive planning
"The introduction of RayStation for the CyberKnife Systems will make it easier for providers with multiple radiotherapy systems to adopt and integrate Accuray technology seamlessly into their clinical operation. As the trend toward standardization on TPS within a radiation department continues to grow, the ability to easily integrate will become increasingly important," said Suzanne Winter, chief commercial officer and senior vice president, R&D at Accuray. "Our goal is to provide customers with options and flexibility in the way they use Accuray radiotherapy delivery systems and has led to the pursuit of multiple paths including valuable partnerships that improve both the functionality of our products and provide greater options for integration. Accuray CyberKnife, Radixact® and TomoTherapy® Systems interface with both RayStation and the Accuray Precision TPS, enabling our customers to optimize their experience and use of our technology over the long-term."